Mar 16, 2017 - TrovaGene Inc. (TROV) reported loss of 31 cents per share in the fourth quarter of 2016, 2 cents wider than the Zacks Consensus Estimate.
Mar 16, 2017 - Catalyst Pharmaceuticals, Inc. (CPRX) reported a loss of 5 cents per share in the fourth quarter of 2016, a penny narrower than the Zacks Consensus Estimate and also narrower than the loss of 7 cents in the year-ago quarter.
Mar 16, 2017 - Jazz Pharmaceuticals plc (JAZZ) recently announced the initiation of patient enrollment in a phase III study evaluating the efficacy and safety of its pipeline candidate, JZP-258, for the potential treatment of adult narcolepsy patients.
Mar 15, 2017 - AstraZeneca plc (AZN) announced positive results from phase III SOLO-2 study which support the potential benefit of marketed drug Lynparza (olaparib) as a maintenance therapy in relapsed ovarian cancer.
Mar 15, 2017 - Arena Pharmaceuticals, Inc. (ARNA) reported earnings of 16 cents per share in the fourth quarter of 2016, as against the year-ago loss of 13 cents and the Zacks Consensus Estimate of a loss of 9 cents.
Mar 10, 2017 - Cogentix Medical, Inc. (CGNT) reported adjusted loss of 14 cents per share in the fourth quarter of 2016.
Mar 05, 2017 - ADUS, AKBA, ALOG, ASNA, ATSG, AVD, BDE, CASY, DAVE, DCO, KFY, KTWO, MEET, MNTX, PLOW, PRTS, THO, WMC
Aug 02, 2016 - Addus HomeCare Corporation (NASDAQ:ADUS) Q2 2016 Results Earnings Conference Call August 2, 2016 9:00 a.m. ET Executives Dirk Allison - President and Chief Executive Officer Brian Poff - Executive Vic
Jul 31, 2016 - [[ADUS]], [[AEGN]], [[AEIS]], [[AMKR]], [[APU]], [[ARE]], [[ATW]], [[BDE]], [[BLKB]], [[CEMP]], [[CGNX]], [[CHGG]], [[CKEC]], [[CONE]], [[CUTR]], [[DAC]],
Jul 29, 2016 - Here, we take a sneak peek at two healthcare stocks scheduled to report their second-quarter figures on Aug 1.